Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Hwangseo | - |
dc.contributor.author | Li, Minghua | - |
dc.contributor.author | Choi, Jungeun | - |
dc.contributor.author | Cho, Hyeongjin | - |
dc.contributor.author | Ham, Seung Wook | - |
dc.date.available | 2019-05-30T02:54:29Z | - |
dc.date.issued | 2009-08 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.issn | 1464-3405 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/23045 | - |
dc.description.abstract | Discovery of Cdc25B phosphatase inhibitors has been actively pursued with the aim to develop anticancer agents. We have been able to identify eight novel Cdc25B inhibitors by means of a computer-aided drug design protocol involving the virtual screening with docking simulations under consideration of the effects of ligand solvation in the binding free energy function. Structural features relevant to the interactions of the newly identified inhibitors with the active-site residues of Cdc25B are also discussed in detail. (C) 2009 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2009.05.078 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.19, no.15, pp 4372 - 4375 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000267900900083 | - |
dc.identifier.scopusid | 2-s2.0-67649968840 | - |
dc.citation.endPage | 4375 | - |
dc.citation.number | 15 | - |
dc.citation.startPage | 4372 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 19 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Cdc25B phosphatase | - |
dc.subject.keywordAuthor | Inhibitor | - |
dc.subject.keywordAuthor | Anticancer agents | - |
dc.subject.keywordAuthor | Virtual screening | - |
dc.subject.keywordAuthor | Docking computation | - |
dc.subject.keywordPlus | DUAL-SPECIFICITY PHOSPHATASE | - |
dc.subject.keywordPlus | GENETIC ALGORITHM | - |
dc.subject.keywordPlus | DOCKING | - |
dc.subject.keywordPlus | SOLVATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.